top of page
shutterstock_317554565_edited.jpg

1 in 17 people worldwide has a rare disease [1]

​

​

We will have a shortfall of 10 million healthcare workers by 2030 [2]

​

​

Less than 2% of the existing primary and tertiary care centre doctors are sufficiently trained in rare diseases [3]

​

​

Family doctors have very limited time availability per patient: 45 seconds in LMIC countries, to 12 minutes in wealthy countries [4]

​

The bottleneck is here... the outcome… 

​

A Diagnostic Odyssey…

 

that can last for years

If we can accelerate the process of ‘primary care referral to specialist care’ we can reduce:

​

 

  • Diagnosis to 55 days [5]

  • Healthcare costs [6]

  • Disease burden  [6]

​

​

 

By resolving these issues, we can accelerate innovation for and across rare diseases for all stakeholders

shutterstock_1225883908 copy.jpeg

Learn About Our Solution

References:

[1] Rare Disease UK. Sourced from https://geneticalliance.org.uk/campaigns-and-research/rare-disease-uk/

[2] Deloitte 2024 Global Health Care Sector Outlook. Sourced from https://www.deloitte.com/global/en/Industries/life-sciences-health-care/

analysis/global-health-care-outlook.html

[3] Ramalle-Gómara E, et al. Orphanet J Rare Dis. 2020 Jan 17;15(1):18

[4] Irving G, et al. BMJ Open. 2017 Nov 8;7(10):e017902

[5] Willmen T, et al.  BMC Health Serv Res. 2023 Aug 23;23(1):904. 

[6] The Cost of Delayed Diagnosis in Rare Disease: A Health Economic Study. Sourced from https://everylifefoundation.org

​

shutterstock_1597219936.jpg

MiRare Ltd

Legally registered in the United Kingdom

Company number: 7376422

​

​

© 2025 by Mirare Ltd.

bottom of page